The research so far indicates that exemestane appears to be safer than tamoxifen and raloxifene, which are associated with a higher risk of endometrial cancer and blood clots, as well as effects such as fatigue and depression. Because of these risks and effects, many women are reluctant to take tamoxifen and raloxifene. Although bone loss has been a concern with other aromatase inhibitors, exemestane did not produce any measurable changes in bone health. Its main side effects included aches, hot flashes, joint pain, and fatigue—but overall these effects were less problematic than those associated with tamoxifen. So overall, exemestane's safety profile appears to be very reassuring.
- Q What should I know about Keytruda before taking it?
- Q What are the possible side effects of Keytruda?
- Q What side effects does Exemestane (Aromasin) cause?
- Q What are aromatase inhibitors?
- Q What is Keytruda?
- Q When should I call my doctor if I am taking Keytruda?